These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 28335994)

  • 21. Proteinase inhibitor 9 is reduced in human atherosclerotic lesion development.
    Hendel A; Cooper D; Abraham T; Zhao H; Allard MF; Granville DJ
    Cardiovasc Pathol; 2012; 21(1):28-38. PubMed ID: 21296596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granzyme B leakage-induced cell death: a new type of activation-induced natural killer cell death.
    Ida H; Nakashima T; Kedersha NL; Yamasaki S; Huang M; Izumi Y; Miyashita T; Origuchi T; Kawakami A; Migita K; Bird PI; Anderson P; Eguchi K
    Eur J Immunol; 2003 Dec; 33(12):3284-92. PubMed ID: 14635036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granzyme B as a novel factor involved in cardiovascular diseases.
    Saito Y; Kondo H; Hojo Y
    J Cardiol; 2011 Mar; 57(2):141-7. PubMed ID: 21168312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cell biology of cross-presentation and the role of dendritic cell subsets.
    Lin ML; Zhan Y; Villadangos JA; Lew AM
    Immunol Cell Biol; 2008; 86(4):353-62. PubMed ID: 18268517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective expression and function of granzyme D in lymphohematopoietic stromal cells.
    Yokoi A; Kina T; Minato N
    Biochem Biophys Res Commun; 1999 Nov; 264(3):768-73. PubMed ID: 10544006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SERPINB12 Is a Slow-Binding Inhibitor of Granzyme A and Hepsin.
    Niehaus JZ; Miedel MT; Good M; Wyatt AN; Pak SC; Silverman GA; Luke CJ
    Biochemistry; 2015 Nov; 54(45):6756-9. PubMed ID: 26497600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-presentation of antigens by dendritic cells: role of autophagy.
    Das M; Kaveri SV; Bayry J
    Oncotarget; 2015 Oct; 6(30):28527-8. PubMed ID: 26337341
    [No Abstract]   [Full Text] [Related]  

  • 28. Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: a potential mechanism for stable renal function in patients with subclinical rejection.
    Rowshani AT; Florquin S; Bemelman F; Kummer JA; Hack CE; Ten Berge IJ
    Kidney Int; 2004 Oct; 66(4):1417-22. PubMed ID: 15458434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.
    Sánchez-Paulete AR; Teijeira A; Cueto FJ; Garasa S; Pérez-Gracia JL; Sánchez-Arráez A; Sancho D; Melero I
    Ann Oncol; 2017 Dec; 28(suppl_12):xii44-xii55. PubMed ID: 28945841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Heat shock protein and antigen cross-presentation].
    Udono H
    Seikagaku; 2012 Oct; 84(10):829-39. PubMed ID: 23240536
    [No Abstract]   [Full Text] [Related]  

  • 31. Differential presentation of endogenous and exogenous hepatitis B surface antigens influences priming of CD8(+) T cells in an epitope-specific manner.
    Riedl P; Reiser M; Stifter K; Krieger J; Schirmbeck R
    Eur J Immunol; 2014 Jul; 44(7):1981-91. PubMed ID: 24723392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses.
    Buzza MS; Hirst CE; Bird CH; Hosking P; McKendrick J; Bird PI
    Cell Immunol; 2001 May; 210(1):21-9. PubMed ID: 11485349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential use of autophagy by primary dendritic cells specialized in cross-presentation.
    Mintern JD; Macri C; Chin WJ; Panozza SE; Segura E; Patterson NL; Zeller P; Bourges D; Bedoui S; McMillan PJ; Idris A; Nowell CJ; Brown A; Radford KJ; Johnston AP; Villadangos JA
    Autophagy; 2015; 11(6):906-17. PubMed ID: 25950899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live Long and Prosper for Antigen Cross-Presentation.
    Münz C
    Immunity; 2015 Dec; 43(6):1028-30. PubMed ID: 26682976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
    Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ
    Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular protein is the source of cross-priming antigen in vivo.
    Shen L; Rock KL
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3035-40. PubMed ID: 14978273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism.
    Martin SJ; Amarante-Mendes GP; Shi L; Chuang TH; Casiano CA; O'Brien GA; Fitzgerald P; Tan EM; Bokoch GM; Greenberg AH; Green DR
    EMBO J; 1996 May; 15(10):2407-16. PubMed ID: 8665848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-Presentation Assay for Human Dendritic Cells.
    Segura E
    Methods Mol Biol; 2016; 1423():189-98. PubMed ID: 27142018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
    Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
    Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The granzyme B inhibitor proteinase inhibitor 9 (PI9) is expressed by human mast cells.
    Bladergroen BA; Strik MC; Wolbink AM; Wouters D; Broekhuizen R; Kummer JA; Hack CE
    Eur J Immunol; 2005 Apr; 35(4):1175-83. PubMed ID: 15739160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.